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CXCR3 Identifies Human Naive CD8+ T Cells with Enhanced
Effector Differentiation Potential
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Maria Metsger,x Alessandra Roberto,* Karolina Pilipow,* Federico S. Colombo,‖
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Federica Sallusto,†,‡,1 and Enrico Lugli*,‖
In mice, the ability of naive T (TN) cells to mount an effector response correlates with TCR sensitivity for self-derived Ags, which can be
quantified indirectly by measuring surface expression levels of CD5. Equivalent findings have not been reported previously in humans.
We identified two discrete subsets of human CD8+ TN cells, defined by the absence or presence of the chemokine receptor CXCR3. The
more abundant CXCR3+ TN cell subset displayed an effector-like transcriptional profile and expressed TCRs with physicochemical
characteristics indicative of enhanced interactions with peptide–HLA class I Ags. Moreover, CXCR3+ TN cells frequently produced IL-2
and TNF in response to nonspecific activation directly ex vivo and differentiated readily into Ag-specific effector cells in vitro. Com-
parative analyses further revealed that human CXCR3+ TN cells were transcriptionally equivalent to murine CXCR3
+ TN cells, which
expressed high levels of CD5. These findings provide support for the notion that effector differentiation is shaped by heterogeneity in the
preimmune repertoire of human CD8+ T cells. The Journal of Immunology, 2019, 203: 000–000.
M
ature naive T (TN) cells are released from the thymus
with predetermined specificities encoded by the
somatically rearranged TCR. The human TN cell
repertoire incorporates .108 different TCRs (1, 2), and a single
TCR can recognize .106 different peptide Ags (3). This inherent
cross-reactivity enables comprehensive recognition of exogenous
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Ags and ensures that TN cells can also interact with self-derived
Ags (4). In mice, TCR interactions with self-derived peptide–MHC
class I (pMHCI) complexes generate tonic signals, which do not
induce effector responses in the absence of inflammation but are
required for the survival of CD8+ TN cells in the periphery (5, 6).
These signals also drive low-level homeostatic proliferation in con-
junction with IL-7, which in turn maintains a diverse repertoire of
clonotypically expressed TCRs in the CD8+ TN cell pool, even under
conditions of reduced thymic output (4, 6).
In response to immune activation, TN cells differentiate into effector
cells that migrate to peripheral tissues and eliminate the inciting Ag.
Once this process is complete, small numbers of Ag-specific T cells
survive and become long-lived memory T (TMEM) cells (7), which
exhibit diverse epigenetic, functional, metabolic, and transcriptional
properties (8–13). TN cells have long been considered largely ho-
mogenous at the population level (11, 14–16). However, the recent
application of emerging single-cell technologies has shown that in-
dividual clonotypes in the TN cell pool can behave very differently in
response to Ag recognition via the TCR. For example, single-cell
adoptive transfer and barcoding experiments in mouse challenge
models have demonstrated that some CD8+ TN cells proliferate ex-
tensively and differentiate into effector cells, whereas other CD8+ TN
cells proliferate to a lesser extent and differentiate into memory cells
(17, 18). Another report described similar heterogeneity in the murine
CD4+ TN cell pool and further suggested that individual cellular tra-
jectories were determined primarily by Ag density and TCR dwell
time (19). All of these studies concluded that classical T cell responses
arise via population averaging rather than uniform behavior (17–19).
In mice, the ability of TN cells to respond to exogenous Ags cor-
relates with the level of cross-reactivity against self-derived Ags, which
can be quantified via the surrogate marker CD5 (20–22). Functionally
distinct subsets of murine TN cells have also been identified on this
basis. For example, CD8+ TN cells that express high levels of CD5 are
hyperresponsive to the homeostatic cytokines IL-2 and IL-7 (23) and
upregulate genes associated with effector differentiation (22), and
CD4+ TN cells that express high levels of CD5 display enhanced
signaling potency downstream of the TCR (20, 21). CD5 has been
used as a proxy for similar purposes in phenotypic analyses of human
CD8+ TN cells (24, 25), However, it remains unclear whether such
functional heterogeneity exists among human CD8+ TN cells and, if so,
to what extent it determines the efficacy of adaptive immune responses.
Materials and Methods
Study approvals
The use of human samples was approved by the relevant Institutional Review
Boards. Ethical approval for the use of buffy coatswas granted by theHumanitas
Research Hospital and the Swiss Federal Office of Public Health (A000197/2).
Ethical approval for the use of peripheral blood (PB) samples from the SardiNIA
study was granted by the Consiglio Nazionale delle Ricerche (0078008/2017).
Ethical approval for the use of lymph nodes (LNs) from patients with head and
neck cancer was granted by the Humanitas Research Hospital (700/2010).
Mouse protocols were approved by the Humanitas Institutional Animal
Care and Use Committee and the ItalianMinistry of Health (452/2018-PR).
Cells
PBMCs were isolated from buffy coats via standard density gradient centri-
fugation. Inmost assays, PBMCswere used immediately after isolation. In some
assays, PBMCs were used after cryopreservation at 280˚C in FBS containing
10% DMSO. Naive CD8+ T cells were enriched by magnetic separation using
a MojoSort Human CD8+ Naive T Cell Isolation Kit (BioLegend), and total
CD8+ T cells were enriched by magnetic separation using an EasySep Human
CD8+ T Cell Isolation Kit (Stemcell Technologies).
Human tissue samples
LNs were surgically removed from patients with head and neck cancer
(age, 31–69 y) and processed as described previously (26). Information on
tissue samples from publicly available mass cytometry by time-of-flight
(CyTOF) data reported in this study can be found in Supplemental Table II
from Wong et al. (27).
Flow cytometry and cell sorting
Fluorochrome-conjugated mAbs were purchased from BD Biosciences,
BioLegend, or eBioscience. All reagents were titrated before use to de-
termine optimal concentrations (28, 29). Chemokine receptor expression
was measured by incubating cells for 20 min at 37˚C. Surface markers
were measured by incubating cells for 20 min at room temperature. In-
tracellular effector molecules were revealed using a Cytofix/Cytoperm Kit
(BD Biosciences). Dead cells were eliminated from the analysis using
Zombie Aqua (BioLegend). Data were acquired using an LSRFortessa or a
FACS Symphony A5 (BD Biosciences) and analyzed with FlowJo software
version 9 (FlowJo). Naive CXCR32 (TNR3
2) and CXCR3+ (TNR3
+) cells
were flow-sorted using a FACSAria III (BD Biosciences). The gating strategy
is depicted in Fig. 1A. Single-stained compensation controls were prepared
using Ab-capture beads (BD Biosciences) as described previously (30).
Age-associated changes in TN cell subsets
TNR3
2 and TNR3
+ cells were quantified in venous blood samples ob-
tained from a cohort of 1938 individuals comprising 815 males and
1123 females (age, 19–105 y) enrolled via the SardiNIA study (31, 32).
To avoid circadian fluctuations and time-dependent artifacts, all sam-
ples were collected in heparin tubes at 8 AM, and immunophenotyping
was performed within 2 h at the recruitment site. CXCR32 and
CXCR3+ cells were quantified among naive-like CD8+ T cells, defined
as CD3+CD42CD45RA+CCR7+CD127+CD1612PD-12. Data were acquired
using a FACSAria III.
Cell culture
Cells were cultured in RPMI 1640 medium supplemented with 10% FBS,
1% penicillin/streptomycin, and 2 mM L-glutamine (R10). To induce cy-
tokine production, flow-sorted TNR3
2 and TNR3
+ cells were stimulated
in a final volume of 200 ml with PMA (10 ng/ml; Sigma-Aldrich) and
ionomycin (500 ng/ml; Sigma-Aldrich) for 6 h in the presence of GolgiPlug
(1 ml/ml; BD Biosciences).
Quantification of TCR excision circles
TNR3
2, TNR3
+, stem cell–like TMEM (TSCM), and bulk CD45RO
+ TMEM
cells were flow-sorted in PBS without Ca2+ and Mg2+, washed twice in the
same buffer, and cryopreserved at 280˚C. Thawed cells were lysed with
proteinase K (100 mg/ml diluted in 10 mM Tris-HCl pH 8; 10 ml/100,000
cells; Roche). TCR rearrangement excision circles (TRECs) were measured
using quantitative PCR (qPCR) as described previously (33) and normalized
to the number of cells in each sample, determined via quantification of FAS.
Quantification of gene expression via qPCR
Total RNAwas purified using an RNeasy Micro Kit with DNAse (Qiagen),
reverse transcribed using a High-Capacity cDNA Reverse Transcription Kit
(Applied Biosystems), and analyzed using qPCR with hydrolysis probes for
CXCR3 (Hs00171041_m1). Reactions were set up using TaqMan Uni-
versal PCR Master Mix, No Amperase UNG (Roche) in MicroAmp Fast
Optical 96-Well Reaction Plates (Applied Biosystems) and processed us-
ing an ABI 7900HT Sequence Detection System (Applied Biosystems).
Expression levels were normalized (Dcycle threshold [Ct]) to the reference
gene B2M (Hs00187842_m1) using the equation 22 (Ct CXCR3 – Ct B2M).
HLA class I tetramers
Fluorochrome-conjugated tetrameric complexes of HLA-A*0201/CMV
pp65495–503 NLVPMVATV (NV9), HLA-A*0201/influenza virus (Flu) ma-
trix protein 1 (M1)58–66 GILGFVFTL (GL9), and HLA-A*0201/MART-126–35
ELAGIGILTV (EV10) were generated and used as described previously (34,
35). Data were acquired from a per sample average of 6 3 106 PBMCs.
Enumeration of Ag-specific TN cell precursors
Total CD8+ T cells and monocytes were isolated from PBMCs via positive se-
lection using magnetic CD8 and CD14 MicroBeads, respectively (Miltenyi Bio-
tec). Two subsets of CD42CD192CD562CD8+CD45RA+CCR7+CD27+CD952
naive cells were identified on the basis of CXCR3 expression among total
CD8+ T cells and flow-sorted using a FACSAria III. CD8+ TMEM cells were
flow-sorted in parallel as controls. Flow-sorted T cells were cultured in
RPMI 1640 medium supplemented with 5% human serum (Swiss Red
Cross), 1% (v/v) nonessential amino acids, 1% (v/v) sodium pyruvate,
50 U/ml penicillin, 50 mg/ml streptomycin, and 2 mM L-glutamine (all
from Invitrogen). Amplified libraries were generated in 96-well plates
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(2000 cells per well) via polyclonal stimulation with PHA (1 mg/ml;
Remel) in the presence of irradiated (45 Gy) allogeneic feeder cells
(2.5 3 104 cells per well) and IL-2 (500 IU/ml) as described previously
(36). Libraries were screened 14–21 d after stimulation by culturing
thoroughly washed T cells (2.5 3 105 cells per well) with autologous ir-
radiated B cells (2.5 3 104 cells per well) pulsed for 3 h with various
Ags. The following Ags were used in these assays: a pool of 386 18-mer
peptides spanning the entire 2004 consensus clade C HIV-1 proteome
(1 mg/ml/peptide); a pool of 669 10-mer peptides spanning the Zika virus
H/PF/2013 proteins Env, NS3, and NS5 (1 mg/ml/peptide); a pool of 198
8–11-mer peptides corresponding to immunogenic regions of CMV
(1 mg/ml/peptide); a pool of 218 8–11-mer peptides corresponding to
immunogenic regions of EBV (1 mg/ml/peptide); and a pool of 351 15-mer
peptides spanning the Flu H1N1 strain A/California/07/2009 proteins hem-
agglutinin, M1, neuraminidase, and nucleoprotein (2 mg/ml/peptide). Pro-
liferation was assessed on d 4 after incubation for 16 h with 1 mCi/ml [3H]
thymidine (Perkin Elmer). Precursor frequencies were calculated based
on the number of negative wells, assuming a Poisson distribution.
Ag-specific T cell proliferation and effector functions
Flow-sorted TNR3
2, TNR3
+, and TMEM cells from CMV-seronegative
donors were labeled with CFSE and cultured at a ratio of 2:1 with irra-
diated autologous monocytes pulsed for 5 h with a human CMV lysate or
a seasonal Flu vaccine (Influvac 2017/2018; Mylan). The respective cul-
tures were supplemented with pooled CMV peptides (1 mg/ml/peptide) or
pooled Flu M1 peptides (2 mg/ml/peptide). On d 10, cells were stimulated
with PMA and ionomycin for 5 h in the presence of brefeldin A for the
final 2 h (all reagents from Sigma-Aldrich). Cell viability was determined
using a LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (Thermo Fisher
Scientific). Intracellular effector molecules were identified by flow cytometry
after fixation/permeabilization with Cytofix/Cytoperm.
TCR sequencing and data analysis
TNR3
2, TNR3
+, and TMEM cells were flow-sorted in triplicate (300,000 cells
per subset) directly into RLT buffer (1.2 ml; final dilution ,20%; Qiagen).
Total RNA was extracted using an RNeasy Mini Kit (Qiagen). Unique
molecular identifier (UMI)-labeled 59 RACE TRB cDNA libraries were
prepared using a Human TCR Profiling Kit (MiLaboratory). All extracted
RNAwas used for cDNA synthesis, and all synthesized cDNAwas used
for PCR amplification. Libraries were prepared in parallel using the
same number of PCR cycles and sequenced using a 150 + 150 bp ap-
proach on a NextSeq 500 (Illumina). Approximately 135 3 106 TRB
reads were obtained in total (1.5 6 0.3 3 106 reads per library), from
which ∼4 3 106 unique UMI-labeled TRB cDNA molecules were
extracted using MIGEC (37) and MiXCR (38) software (53,000 6
10,000 molecules per library), with the MIGEC threshold set to at least
two reads per UMI. Each library contained an average of 40,000 6
10,000 functional (in-frame with no stop codons) CDR3 nucleotide sequence
variants (unique TRB clonotypes). Averaged physicochemical characteristics
of the 5 aa residues located in the middle of the TRB CDR3 sequence
(weighted by clonotype size) were analyzed using VDJtools software (39).
These characteristics included the estimated energy of the interaction be-
tween cognate peptide and the TRB CDR3 (40), the strength of this inter-
action as a derivative of energy, volume, and hydrophobicity (Kidera factor
4) (41, 42). Diversity metrics were analyzed using VDJtools after nor-
malization to 5000 randomly selected UMI-labeled TRB cDNA molecules
per sample.
DNA microarrays
Flow-sorted TNR3
2, TNR3
+, and TMEM cells were washed twice in PBS
without Ca2+ and Mg2+, resuspended in RLT buffer (Qiagen), and pro-
cessed as described previously (43). Microarray probe fluorescence signals
were converted to expression values using the robust multiarray average
procedure in the Bioconductor Affy package (44). Log2 expression values
for a total of 32,500 custom probe sets were calculated from background-
adjusted and quantile-normalized fluorescence intensities using median polish
summarization and custom chip definition files for the Affymetrix Human
Transcriptome Array 2.0 based on Entrez genes (hta20_Hs_ENTREZG version
21.0.0). All data analyses were performed in R version 3.4.4. Differentially
expressed genes (DEGs) were identified via paired comparisons of TNR3
2 and
TNR3
+ cells using the limma algorithm in the same R package (45).
Pathway analysis of microarray data
Mouse gene identifications obtained from comparisons between TNR3
+
and CD5lo or CD5hi cells were converted into the corresponding human
orthologous genes using the HUGO Gene Nomenclature Committee
Database (https://www.genenames.org/cgi-bin/hcop). Pathway analysis
was performed using gene set enrichment analysis (GSEA) software
(http://software.broadinstitute.org/gsea/msigdb/) and gene sets from
the Molecular Signatures Database (version 6.2). Specific gene sets
included the c2 (c2.cp.reactome.v6.2) and immunological signatures
collections (c7.all.v6.2). GSEAwas applied to log2-transformed expression
data obtained from TNR3
2 and TNR3
+ cells. Gene sets were considered
significantly enriched at false discovery rate (FDR) values # 0.05 using
Signal2Noise as a metric across 1000 permutations.
Mouse TN cell sorting and RNA sequencing
Spleens were obtained from 12-wk-old male C57BL/6 mice (Charles River
Laboratories) and mechanically smashed through a cell strainer with a pore
size of 40 mm. Splenocytes were enriched for CD8+ T cells using a
MojoSort Mouse CD8+ T Cell Isolation Kit (BioLegend). Flow-sorted cells
were lysed in RLT buffer (50 ml; Qiagen) containing RNAse Inhibitor
(1 ml; Qiagen). Total RNAwas extracted using an RNeasy Micro Kit (Qiagen).
RNA sequencing (RNAseq) libraries were prepared using a SMART-Seq v4
Ultra Low Input RNA Kit for Sequencing (Takara Clontech). Libraries were
pooled at equimolar concentrations and sequenced on a NextSeq 500
(Illumina). At least 20 3 106 single-end reads (75 bp) were generated
per sample.
RNAseq data analysis
Raw sequence data were quality controlled using FastQC (http://www.
bioinformatics.babraham.ac.uk/projects/fastqc). Single-end reads (75 bp)
were then aligned to theMus musculus reference genome (Ensembl assembly
GRCm38) using STAR (version 2.5.1b) (46). Alignments were performed
using default parameters. Reads associated with annotated genes were
counted using the HTSeq and “-quantmode TranscriptomeSAM GeneCounts”
options. Differential gene expression between mouse TN subsets was assessed
using the edgeR package (version 3.22) (47). Benjamini-Hochberg correction
was applied to estimate the FDR.
t-distributed stochastic neighbor embedding analysis of
high-dimensional CyTOF data
Public CyTOF data obtained from tonsils, spleen, liver, gut, skin, and lungs
(27) were downloaded from https://flowrepository.org/. Debarcoded sam-
ple files were imported into FlowJo (version 9) and concatenated into a
single.fcs file (∼2500 events per sample), which was then subjected to
t-distributed stochastic neighbor embedding (tSNE) analysis (Barnes-Hut
implementation) using the following parameters: iterations, 1000; perplexity,
40; initialization, deterministic; u, 0.5; and h, 200. All markers listed in Fig. 1E
were included in the analysis, except CXCR3.
Statistics
Statistical analyses were performed using GraphPad Prism version 7 or
R software version 3.4.4. Significance was assigned at p , 0.05 unless
stated otherwise. Specific tests are indicated in the figure legends for
each comparison.
Data availability
Raw microarray and RNAseq data are available via the Gene Expression
Omnibus (https://www.ncbi.nlm.nih.gov/geo/) under accession number
GSE125102. Demultiplexed fastq TCR sequencing data are available via the
ArrayExpress Database at The European Molecular Biology Laboratory–
European Bioinformatics Institute (www.ebi.ac.uk/arrayexpress) under ac-
cession number E-MTAB-7638.
Results
CXCR3 identifies two subsets of TN cells in humans
A previous flow cytometric analysis of human TN cell pop-
ulations (9), identified using stringent phenotypic criteria
(CD45RO2CCR7+CD27+CD952) to exclude memory contaminants
(48, 49), demonstrated that CXCR3 was not uniformly expressed by
CD8+ TN cells. Instead, there was a clear bimodal distribution,
which distinguished CXCR32 (TNR3
2) and CXCR3+ (TNR3
+)
cells (Fig. 1A). To confirm this finding, we flow-sorted TNR3
2 and
TNR3
+ cells and evaluated CXCR3 mRNA expression via qPCR.
In accordance with the protein data, CXCR3 mRNA was readily
detected in TNR3
+ cells, but was uncommon in TNR3
2 cells
(Fig. 1B). CXCR3 protein expression was detected at equivalent
The Journal of Immunology 3
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FIGURE 1. CXCR3 identifies two subsets of TN cells in humans. (A) Representative flow cytometric analysis of CXCR3 expression on the surface of TN
cells (CD45RO2CCR7+CD27+CD952). Numbers indicate the percentage of cells in each gate. (B) Expression of CXCR3 relative to B2M mRNA in flow-
sorted TNR3
2 and TNR3
+ cells (n = 5). Each color indicates a different donor. Data are shown as mean6 SEM. n.d., not detected. (C) Frequency analysis of
T cell subsets in PB samples from healthy individuals (n = 26). Data are shown as mean 6 SEM. TSCM (CD45RO
2CCR7+CD27+CD95+); TCM, central
TMEM (CD45RO
+CCR7+); TEM, effector TMEM (CD45RO
+CCR72); and TTE, terminal effector T (CD45RO
2CCR72) cells. (D) tSNE map displaying the
surface immunophenotypes of circulating TNR3
2, TNR3
+, and TMEM cells overlaid on the total CD8
+ T cell population. Left, TNR3
2 (red); right, TNR3
+
(blue). Data were obtained using CyTOF. Individual markers are shown in (E). (E) Heatmap showing percent expression of the indicated markers among
CD8+ T cell subsets identified in PB. Data were obtained using CyTOF. Subsets were defined as in (C). (F) Frequency analysis of TNR3
2 and TNR3
+ cells
among total CD8+ T cells isolated from human tonsils (n = 5), spleen (n = 3), liver (n = 3), gut (n = 6), skin (n = 5), and lungs (n = 4). Data are shown
as mean 6 SEM. *p , 0.05 (paired t test). (G) Percent ratio of TNR3
+/TNR3
2 cells in paired LN and PB samples. Data are shown as mean 6 SEM.
(H) Frequency analysis of circulating TNR3
2 and TNR3
+ cells in 1938 individuals (age, 19–105 y). Red lines indicate linear regression. Effect size and
p value are shown for each correlation.
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levels on the surface of CD8+ TN cells with two different anti-
CXCR3 mAbs (Supplemental Fig. 1A). However, a partial loss
of CXCR3 expression was observed after cryopreservation
(Supplemental Fig. 1B), as noted previously (50). A vast majority of
our assays were therefore performed using freshly isolated PBMCs.
We then quantified TN and TMEM cell subsets in the PB of
healthy individuals and found that TNR3
+ cells were ∼3-fold
more abundant than TNR3
2 cells under physiological conditions
(Fig. 1C). To gain further insights into the surface phenotype of
these two subsets, we took advantage of a publicly available CyTOF
data set reported by Wong et al. (27) who investigated the surface
proteome of CD8+ T cells from various human tissues. Dimen-
sionality reduction via tSNE revealed that TNR3
2 and TNR3
+ cells
from PB (Fig. 1D) and tissues (Supplemental Fig. 1C) mapped to
similar regions of the plot, indicating a common phenotype, whereas
both subsets were distinct from conventional CD45RO+ TMEM cells. A
simultaneous analysis of surface markers involved in differentiation,
homing, and activation/costimulation further revealed that TNR3
2 and
TNR3
+ cells shared phenotypic traits of TN cells, including the pres-
ence of CD45RA, CD27, CD62L, and CD127, and the absence of
molecules such as CD49a, CD49d, CD57, CD95, CCR5, CLA, and
PD-1 (Fig. 1E, Supplemental Fig. 1D) (11).
TN cells preferentially migrate to secondary lymphoid organs
rather than mucosal tissues (51, 52). In line with this general di-
chotomy, TNR3
2 and TNR3
+ cells were relatively abundant in hu-
man tonsils, less so in spleen and liver, and virtually undetectable in
gut, skin, and lungs (Fig. 1F). On the basis of these data, it seems
unlikely that CXCR3 regulates TN cell trafficking under physio-
logical conditions. Moreover, we found very similar frequencies of
TNR3
2 and TNR3
+ cells in paired LN and PB samples (Fig. 1G),
and CD8+ TN cells almost invariably lacked the tissue-residency
markers CD69 and CD103, irrespective of anatomical localization
and expression of CXCR3 (Supplemental Fig. 1D).
TN cells become less frequent with age (53). To investigate the
impact of aging on TN cell subsets, we analyzed PB samples
obtained from a previously reported cohort of 1938 healthy indi-
viduals, spanning an age range from 19 to 105 y (31, 32). We found
that TNR3
2 and TNR3
+ cells declined with age, but at slightly
different rates, such that TNR3
+ cells became progressively more
common in the CD8+ TN cell pool (Fig. 1H).
True naivety of TNR3
+ cells
Previous work identified CXCR3+ TN-like cells in the CD4
+ lineage
as memory precursors of Th1 cells (54). A more recent study further
suggested that CXCR3+ TN-like cells in the CD8
+ lineage were
young TMEM cells (55). We therefore performed a number of
different assays to characterize the naive and memory proper-
ties of TNR3
2 and TNR3
+ cells.
The replicative history of T cell populations can be assessed by
measuring TRECs, which are progressively diluted upon cell di-
vision (56). In ex vivo assays, we found that TRECs were ∼2-fold
more common in TNR3
2 cells compared with TNR3
+ cells,
∼4-fold more common in TNR32 cells compared with TSCM cells
(9), and ∼25-fold more common in TNR32 cells compared with
TMEM cells (Fig. 2A). TNR3
+ cells therefore underwent on average
one additional round of division in vivo relative to TNR3
2 cells,
suggesting a link between homeostatic proliferation and the ac-
quisition of CXCR3.
Truly naive T cell populations lack clonal expansions specific for
exogenous Ags, but occasionally harbor large numbers of pre-
cursors specific for certain self-derived Ags (57). In line with these
predictions, HLA-A*0201–restricted CD8+ T cells specific for
immunodominant epitopes derived from CMV and Flu were un-
common in the TNR3
2 and TNR3
+ cell subsets, but abundant
in the TSCM and TMEM cell subsets (9), whereas HLA-A*0201–
restricted CD8+ T cells specific for an immunodominant epitope
derived from MART-1 were common in TNR3
2 and TNR3
+ cell
subsets (Fig. 2B, 2C). A recent study identified a rare population
of memory cells with a TN-like phenotype (TMNP) that expressed
high levels of CD49d and CXCR3 and rapidly produced IFN-g in
response to stimulation with PMA and ionomycin (58). CD8+
T cells specific for epitopes derived from persistent viruses, such
as CMVand EBV, but not acute viruses, such as Flu, were detected
in the TMNP cell pool (58). In contrast, we detected Flu-specific
CD8+ T cells, but not CMV-specific CD8+ T cells, in the TMNP
cell subset, which comprised ∼0.5% of the TNR3+ cell population
(Fig. 2B, 2C).
Our findings with the MART-1–derived epitope suggested that
Ag-specific precursors were not compartmentalized to particular
subsets of TN cells. To confirm this inference at the level of ex-
ogenous Ags, we screened amplified libraries of TNR3
2, TNR3
+,
and TMEM cells with peptide-pulsed APCs (36). Similar frequen-
cies of CD8+ T cells specific for previously unencountered (HIV-1
and Zika virus) and more prevalent viruses (CMV, EBV, and Flu)
were detected in the TNR3
2 and TNR3
+ cell pools (Fig. 2D). An
exception was noted in one donor, who harbored remarkably
high frequencies of HIV-1–specific TNR3
2 cells, but not HIV-
1–specific TNR3
+ cells, potentially indicating degenerate recog-
nition by cross-reactive TCRs (59). As expected, CD8+ T cells
specific for previously unencountered viruses were largely undetect-
able in the TMEM cell pool, whereas CD8
+ T cells specific for more
prevalent viruses were common in the TMEM cell pool (Fig. 2D).
TNR3
+ cells are biased toward effector differentiation
In further experiments, we assessed the relationship between TNR3
2,
TNR3
+, and TMEM cells at the level of gene expression. Principal
component analysis of the entire data set revealed that TNR3
2 and
TNR3
+ cells were largely distinct from conventional TMEM cells
(Fig. 3A). Paired analysis of samples isolated from individual
donors (n = 4) identified 345 genes that were differentially expressed
(p, 0.01) between TNR3
2 and TNR3
+ cells (Supplemental Table I).
The effector/memory–related transcripts EOMES,MYB, and ANXA1
(60), and the costimulatory receptor CD226, which encodes DNAX
accessory molecule-1 (DNAM-1), were preferentially expressed in
TNR3
+ cells (Fig. 3B). A total of 2567 DEGs, including BHLHE40,
a transcription factor associated with effector differentiation, and
NT5E, which encodes CD73, a surface enzyme involved in the
generation of adenosine, were identified using a less stringent
cut-off (p , 0.05; Supplemental Table I). Differential expression
of CD73 and CD226 was further confirmed at the protein level
via flow cytometry (Supplemental Fig. 1E). In contrast, transcrip-
tion factors associated with the regulation of thymocyte differenti-
ation, such as RUNX1, SOX4, and IKZF1, were overexpressed in
TNR3
2 cells (Fig. 3B, Supplemental Table I).
To capture global trends in gene expression, we performed
GSEA. This approach revealed that gene sets involved in the cell
cycle, transcriptional activity, and the respiratory electron transport
chain (REACTOME Database), as well as transcripts associated
with effector and memory activity (Immunological Signatures
Database), were strongly enriched in TNR3
+ versus TNR3
2 cells
(FDR , 0.001; Fig. 3C). These findings suggested that TNR3
+
cells were better poised to differentiate and acquire effector func-
tionality compared with TNR3
2 cells. To test this hypothesis, we
stimulated flow-sorted TNR3
2, TNR3
+, and TMEM cells directly ex
vivo with PMA and ionomycin. Twice as many TNR3
+ cells pro-
duced IL-2, potentially reflecting decreased expression of IKZF1,
an inhibitor of IL-2 production in CD8+ TN cells (61), and TNF
compared with TNR3
2 cells (Fig. 3D). In line with their naive
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status, however, both TNR3
2 and TNR3
+ cells largely failed to
produce IFN-g, unlike TMEM cells (Fig. 3D). The corresponding
subsets were also flow-sorted from CMV-seronegative donors and
cultured for 10 d with autologous monocytes presenting epitopes
derived from CMV. Ag-driven proliferation was observed in the
TNR3
2 and TNR3
+ cell subsets, but not in the TMEM cell subset
(Fig. 3E, 3F). Importantly, CMV-specific TNR3
+ cells that un-
derwent proliferation, assessed via serial dilution of CFSE, pro-
duced more IFN-g and perforin and tended to produce more TNF
compared with TNR3
2 cells after stimulation with PMA and
ionomycin on d 10 (Fig. 3G, 3H).
TNR3
2 and TNR3
+ cells express qualitatively distinct TCRs
In mice, enhanced TCR reactivity against self-derived Ags cor-
relates with surface expression of CD5 and determines the effi-
ciency of TN cell recruitment in response to foreign Ags (20–22).
We found that surface levels of CD5 were comparable between
TNR3
2 and TNR3
+ cells (Fig. 4A). However, the strength of TCR
interactions with pMHCI molecules can also be inferred from the
physicochemical properties of TRB CDR3 sequences (23, 40, 62,
63), as was recently proposed for human and mouse regulatory
T cells (64–66) and CD4+ T cells (67). We therefore used a high-
throughput approach to sequence the TRB repertoires of flow-
sorted TNR3
2, TNR3
+, and TMEM cells. Importantly, TNR3
2 and
TNR3
+ cells from individual donors exhibited similar patterns of
TRBV-TRBJ use (Jenson-Shannon divergence analysis), indicat-
ing a close relationship, whereas distinct patterns of TRBV-TRBJ
use were observed in the corresponding TMEM cell subsets (Fig. 4B).
Repertoire diversity was comparably high in the TNR3
2 and TNR3
+
cell subsets, as expected for truly naive populations, but much lower
in the corresponding TMEM cell subsets, quantified using normalized
Shannon-Weiner and Chao1 metrics (Fig. 4C, 4D). We then deter-
mined the averaged physicochemical properties of the 5 aa residues
located in the middle of each TRB CDR3 sequence, which domi-
nate interface contacts with the peptide component of pMHCI
molecules (62). At the population level, increased hydrophobicity
FIGURE 2. True naivety of TNR3
+ cells. (A) TREC
copies relative to TNR3
2 cells in CD8+ T cell subsets
isolated from PB (TNR3
2, TNR3
+, and TMEM cells,
n = 10; TSCM cells, n = 4). Numbers indicate fold
change relative to TNR3
2 cells. Data are shown as
mean 6 SEM. *p , 0.05, **p, 0.01, ****p, 0.0001
(nonparametric ANOVA with Dunn posttest). (B)
Representative flow cytometric analysis showing
NV9 (CMV), GL9 (Flu), and EV10 (MART-1) tet-
ramer+ events versus CXCR3 expression among
CD8+ T cell subsets in PB. Plots on the top row show
CD45RO2CCR7+CD27+CD952 TN cells subgated
as TNR3
2, TNR3
+, and TMNP cells. (C) Frequency
analysis of tetramer+ events as shown in (B) (CMV, n = 6;
Flu, n = 7; MART-1, n = 8). Data are shown as mean 6
SEM. n.d., not detected. *p , 0.05, **p , 0.01 (non-
parametric ANOVA with Dunn posttest). (D) Frequency
analysis of Ag-specific CD8+ T cell precursors among
TNR3
2, TNR3
+, and TMEM cells. Bars indicate median
values. Each dot represents one donor (n = 3).
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FIGURE 3. TNR3
+ cells are biased toward effector differentiation. (A) Principal component analysis based on the expression levels of genes with
coefficients of variation larger than the 90th percentile of the coefficients of variation in the entire data set, determined via microarray analysis. Labels
indicate donors (n = 4). (B) Heatmap showing DEGs (p , 0.01) in TNR3
2 versus TNR3
+ cells (n = 4). The most relevant genes associated with immune
functions are listed. (C) Normalized enrichment score (NES) and FDR for each gene signature enriched in TNR3
+ versus TNR3
2 cells, determined via
GSEA. (D) Frequency analysis of cytokine production by TNR3
2, TNR3
+, and TMEM cells after stimulation with PMA and ionomycin (TNR3
2 and TNR3
+,
n = 6; TMEM cells, n = 2). Data are shown as mean 6 SEM. *p , 0.05, **p , 0.01 (paired t test). Statistics were omitted for (Figure legend continues)
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(lower Kidera factor 4), lower energy (40, 63), and higher strength
and volume indices, calculated using VDJtools (39), were observed
for TRB CDR3 sequences in the TNR3
+ cell pool compared with
TRB CDR3 sequences in the TNR3
2 cell pool (Fig. 4E).
TNR3
+ cells are transcriptionally equivalent in humans
and mice
To corroborate these findings, which suggested that TCRs with
higher intrinsic affinities for self-derived Ags were more prevalent
in the TNR3
+ cell pool compared with the TNR3
2 cell pool, we
extended our analysis to the murine CD8+ TN compartment (de-
fined as CD44loCD62Lhi). Murine TNR3
+ cells were contained
almost exclusively within the CD5hi fraction (Fig. 5A, 5B). These
cells were shown previously to respond more vigorously to foreign
Ags compared with CD5lo and CD5hi TN cells (22). To characterize
murine TNR3
+ cells in more detail, we flow-sorted CD5loCXCR32
(CD5lo), CD5hiCXCR32 (CD5hi), and CD5hiCXCR3+ (TNR3
+)
cells from the splenic CD44loCD62Lhi TN cell pool, together with
CD44hi TMEM cells, and defined the transcriptional profile of each
subset using RNAseq. All three TN cell subsets were clearly distinct
at the transcriptional level compared with the conventional TMEM
cell subset, based on the biological coefficient of variation (Fig. 5C).
However, we also identified 636 DEGs (FDR , 0.001) among the
TN cell subsets (Fig. 5D, Supplemental Table II). In addition to Cd5
and Cxcr3, murine TNR3
+ cells overexpressed genes associated
with effector differentiation, including Tbx21, Ccl5, Irf8, Hopx,
Junb, Fos, and Jun (Fig. 5D, Supplemental Table II), and with less
stringent criteria (FDR , 0.05), underexpressed genes associated
with a naive phenotype, including Lef1 and Ccr7, compared with
both CD5lo and CD5hi TN cells (Supplemental Table II). Impor-
tantly, DEGs identified in the corresponding human TN cell subsets,
such as Ccr9, Eomes, Nt5e, Myb, Sox4, and Ikzf1, were also dif-
ferentially expressed among murine TN cell subsets (Fig. 5D,
Supplemental Table II). In accordance with these data, genes up-
regulated in murine TNR3
+ versus CD5lo (n = 221; FDR , 0.0001)
and murine TNR3
+ versus CD5hi cells (n = 37; FDR, 0.0001) were
also preferentially enriched in human TNR3
+ versus TNR3
2
cells, indicating close transcriptional parallels between TNR3
+
cells in different species (Figs. 3C, 5E).
Discussion
It has become apparent in recent years that the classically defined
TN cell pool incorporates subpopulations of cells with memory-
like properties, including TSCM cells (9, 51) and TMNP cells (58).
In this study, we found that truly naive T cells can also exhibit
distinct characteristics, both in humans and in mice. Specifically,
we identified two discrete subsets of CD8+ TN cells in each spe-
cies, defined by the absence or presence of the chemokine receptor
comparisons with TMEM cells. (E) Representative flow cytometric analysis of CFSE dilution in TNR3
2, TNR3
+, and TMEM cells after stimulation for 10 d
with autologous monocytes presenting epitopes derived from CMV. (F) Frequency analysis of TNR3
2, TNR3
+, and TMEM cells that proliferated (CFSE
lo) in
response to stimulation for 10 d as in (E) (n = 5). Data are shown as mean 6 SEM. *p, 0.05 (nonparametric ANOVA). (G) Representative flow cytometric
analysis of effector molecules produced by CFSElo TNR3
2 and CFSElo TNR3
+ cells [identified as in (E)] after stimulation with PMA and ionomycin.
Numbers indicate the percentage of cells in each gate. (H) Mean summary of data obtained as in (G). Each dot represents a different donor. *p , 0.05,
***p , 0.001 (paired t test).
FIGURE 4. TNR3
2 and TNR3
+ cells express qualitatively distinct TCRs. (A) Representative flow cytometric analysis of CD5 expression on the surface of
human TNR3
2, TNR3
+, and TMEM cells. Similar data were obtained from three other donors. (B) Cluster analysis of TRBV-TRBJ use among TNR3
2,
TNR3
+, and TMEM cells (TNR3
2 and TNR3
+, n = 5; TMEM cells, n = 3). (C) Normalized Shannon-Wiener diversity index and (D) Chao1 diversity index
calculated for 5000 unique UMI-labeled TRB CDR3 molecules from two independent experiments (n = 11). ***p, 0.001 (Tukey range test). (E) Averaged
(weighted per clonal size) Kidera factor 4 (KF4), Miyazawa-Jernigan energy (MJenergy), strength, and volume indices for the 5 aa residues located the
middle of the TRB CDR3 sequences extracted from the TNR3
2 and TNR3
+ cell repertoires [details as in (D)]. **p , 0.01, ***p , 0.001, ****p , 0.0001
(paired t test).
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CXCR3. In humans, TNR3
+ cells more frequently produced IL-2
and TNF in response to nonspecific activation directly ex vivo,
differentiated more readily to acquire various effector functions
in vitro after stimulation with cognate Ag, and overexpressed a
distinct array of genes compared with TNR3
2 cells. Repertoire
analysis further indicated that TNR3
+ cells expressed TCRs with
enhanced Ag sensitivity, despite comparably high levels of diversity
in the TNR3
2 and TNR3
+ cell pools. Moreover, human TNR3
+ cells
were phenotypically and transcriptionally equivalent to murine
TNR3
+ cells, which expressed high levels of CD5. It is notable
in this regard that CXCR3 has also been shown to demarcate
functionally superior CD8+ T cells that respond to innate sig-
nals in the murine CD44hi memory compartment (68, 69).
In mice, the ability of CD8+ TN cells to respond to infectious
agents has been shown to correlate with TCR sensitivity for self-
derived Ags (22), which can be assessed by measuring surface
expression of CD5 (20–23). Accordingly, genes associated with
the cell cycle and effector differentiation, including Tbx21 and
Eomes, were upregulated in CD5hi TN cells compared with CD5
lo
TN cells (22). Some murine CD5
hi TN cells also expressed CXCR3
(22). We found that these murine TNR3
+ cells overexpressed several
transcripts associated with effector differentiation compared with
both CD5lo and CD5hi cells, closely mirroring the transcriptional
identity of human TNR3
+ cells. It remains unclear to what extent
CD5 can be used to identify functionally distinct subsets of human
TN cells (24, 25). However, TN cells with a proclivity for effector
differentiation were clearly defined in our data set on the basis of
CXCR3 expression, thereby providing a unique identifier for the
isolation of truly naive precursors with functional properties that
may be useful in the context of various immunotherapies.
Recent data have shown that memory-like CD8+ T cells are
retained in the skin and thymus of nonimmunized mice via a
CXCR3-dependent mechanism (70). We found that TNR3
+ cells
were virtually excluded from mucosal sites, including the skin,
but were relatively abundant in PB and LNs. It also seems likely
that TNR3
2 and TNR3
+ cells recirculate continuously between
these latter two compartments, because neither subset expressed
the tissue-residency markers CD69 and CD103. In line with these
findings, another study reported that CXCR3-dependent signaling
was undetectable in naive and memory CD8+ T cells directly ex
vivo, but increased with stimulation via the TCR (71). Moreover,
the CXCR3 ligands CXCL9, CXCL10, and CXCL11 are poorly
expressed at steady-state and only become upregulated in the context
of inflammation (72, 73). The functional and migratory advantages
of TNR3
+ cells relative to TNR3
2 cells may therefore be confined to
the setting of immune activation, as described previously for murine
CXCR3+ TCM cells, which localize rapidly to peripheral areas of
the relevant LNs in response to challenge with previously en-
countered Ags (73).
TRECs were modestly diluted in TNR3
+ cells compared with
TNR3
2 cells, indicating a slightly higher rate of homeostatic turn-
over in vivo, akin to that observed previously for CD5hi TN cells
FIGURE 5. TNR3
+ cells are transcriptionally equivalent in humans and mice. (A) Left: representative flow cytometric analysis of CD5 and CXCR3
expression on the surface of murine CD8+ TN cells (CD44
loCD62Lhi). Right: postsort purity analysis of murine CD5lo, CD5hi, and TNR3
+ cells. (B) Mean
fluorescence intensity (MFI) of CD5 expression on the surface of murine TNR3
2 and TNR3
+ cells, gated as CD44loCD62LhiCXCR32 and
CD44loCD62LhiCXCR3+, respectively (n = 5). ****p , 0.0001 (paired t test). (C) Biological coefficient of variation (BCV) plot derived from RNAseq
profiles of murine CD5lo, CD5hi, and TNR3
+ cells isolated as in (A) (n = 5). Bulk memory CD8+ T cells are shown as CD44hi (n = 3). (D) Heatmap showing
DEGs (FDR , 0.0001) among CD5lo, CD5hi, and TNR3
+ cells isolated as in (A). The most relevant genes associated with immune functions are listed.
(E) GSEA plots showing murine TNR3
+ versus CD5hi (top) and murine TNR3
+ versus CD5lo gene sets (bottom) that were significantly enriched in human
TNR3
+ versus TNR3
2 cells (Fig. 3C).
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compared with CD5lo TN cells in lymphopenic mice (23). Ho-
meostatic proliferation may even drive the acquisition of CXCR3
(74). In this scenario, TNR3
+ cells would arise as a natural conse-
quence of enhanced tonic signaling via qualitatively distinct TCRs
with a predilection for self-derived Ags. Alternatively, TNR3
+ cells
may be preprogrammed during thymic development to respond
more vigorously to homeostatic signals in the periphery. In line with
this possibility, a recent study demonstrated that murine TN cells
generated early in life, which resembled TNR3
+ cells at the tran-
scriptional level, were more prone to effector differentiation than
murine TN cells generated later in life (75).
In summary, we have shown that humans and mice harbor at least
two distinct subsets of TN cells, defined by the absence or presence
of CXCR3. The greater effector differentiation potential of TNR3
+
cells bestows obvious kinetic advantages, enabling timely immune
responses in the face of perceived threats to the host (22). The
biological role of TNR3
2 cells is less clear. A parallel repertoire of
qualitatively distinct TCRs may nonetheless be required to cover
any potential “holes” in the spectrum of adaptive immune speci-
ficities, even at the cost of a selection disadvantage in the overall
TN cell pool (76). On this basis, we propose that the preimmune
repertoire is organized into functionally and transcriptionally discrete
subsets, which fulfill different roles in the immune system, collec-
tively ensuring balanced and comprehensive effector responses to
exogenous Ags.
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Figure S1. Identification of CXCR3+ human CD8+ TN cells. (A) Representative flow cytometric analysis of 
CXCR3 expression on the surface of CD8+ TN cells, detected using two different mAbs. Similar data were obtai-
ned from four other donors. (B) Frequency analysis of CXCR3 expression on the surface of CD8+ TN cells 
before and after cryopreservation (n = 5). Data are shown as mean ± SEM. * p < 0.05 (paired t-test). (C) tSNE 
map displaying the surface immunophenotypes of TNR3–, TNR3+, and TMEM cells from the indicated tissues 
overlaid on the corresponding total CD8+ T cell populations. Data were obtained using CyTOF. Individual mar-
kers are shown in B. (D) Heatmap showing percent expression of the indicated markers among CD8+ T cell 
subsets identified in the indicated tissues. Data were obtained using CyTOF. Subsets were defined as in Figure 
1C. (E) Mean fluorescence intensity (MFI) of CD73 and CD226 expression on the surface of TNR3– and TNR3+ 
cells (n = 4). * p < 0.05 (paired t-test). Related to Figure 3.
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